← Back to Search

Biologic Care Pathway for Crohn's Disease

N/A

Recruiting

Research Sponsored by Jennifer Jones

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 12

Awards & highlights

Study Summary

This trial aims to study the use of standardized care pathways for patients with Inflammatory Bowel Disease (IBD) to improve treatment outcomes. The researchers will investigate how implementing a Biologic Care Pathway

Who is the study for?

This trial is for adults over 18 with Crohn's Disease, Ulcerative Colitis, or other IBDs who are starting anti-TNF biologic therapy. It excludes those with severe intestinal complications, active infections, cancer, or any reason they can't have biologic treatments.Check my eligibility

What is being tested?

The study tests a Biologic Care Pathway (BCP) to see if it improves patient outcomes in IBD treatment compared to usual care without BCP. The focus is on the integration of BCP into clinical practice and its effects on health outcomes and healthcare efficiency.See study design

What are the potential side effects?

While specific side effects aren't listed for the pathway itself, typical risks associated with anti-TNF biologics include infection risk increase, potential allergic reactions, and possible worsening of heart failure among others.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

EQ5D Score

Secondary outcome measures

Emergency room visits

ambulatory care visits

disease-related surgery

+2 more

Other outcome measures

CRP concentration

Fecal calprotectin

HBI Index Score

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Biologic Care PathwayExperimental Treatment1 Intervention

Care through a biologic care pathway

Group II: ControlActive Control1 Intervention

Care as usual

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityOTHER

258 Previous Clinical Trials

83,672 Total Patients Enrolled

Jennifer JonesLead Sponsor

2 Previous Clinical Trials

620 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to apply and participate in this ongoing research study?

"As per clinicaltrials.gov, this ongoing medical trial is actively seeking participants. The initial posting of the trial occurred on March 25th, 2024, with the most recent update noted on March 27th, 2024."

Answered by AI

What is the current number of individuals being selected to participate in this clinical investigation?

"Affirmative, the content on clinicaltrials.gov indicates that this research study is actively seeking subjects. The initial posting date was 3/25/2024 and the most recent update occurred on 3/27/2024. To complete enrollment, a total of 182 individuals are sought from one designated site."

Answered by AI

Is there an age limit that excludes patients over 55 years old from participating in this trial?

"Eligible candidates for this research endeavor must be between 18 and 99 years old. It is worth noting that there are numerous trials available specifically tailored for individuals under 18 as well as those aged over 65, with a total of 123 and 402 studies respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway

Jennifer Jones 2024. "Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06030882.

All > Inflammatory Bowel Disease > Ibd